Title : EGFR mutations as a predictive marker of cytotoxic chemotherapy.

Pub. Date : 2012 Aug

PMID : 22521649






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 When we analyzed patients with an EGFR exon 19 deletion, the PFS of the taxane treated cases was better than that of the gemcitabine treated cases (5.3 months vs 3.7 months, P=0.012). taxane epidermal growth factor receptor Homo sapiens
2 CONCLUSIONS: Our current data indicate that lung cancer patients with EGFR-mutations had longer PFS with taxane than gemcitabine when receiving a platinum-based doublet regimen. taxane epidermal growth factor receptor Homo sapiens